The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation

Gerald J Berry; Margaret M Burke; Claus Andersen; Patrick Bruneval; Marny Fedrigo; Michael C Fishbein; Martin Goddard; Elizabeth H Hammond; Ornella Leone; Charles Marboe; Dylan Miller; Desley Neil; Doris Rassl; Monica P Revelo; Alexandra Rice; E Rene Rodriguez; Susan Stewart; Carmela D Tan; Gayle L Winters; Lori West; Mandeep R Mehra; Annalisa Angelini

doi:10.1016/j.healun.2013.08.011

The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation

Gerald J Berry, Margaret M Burke, Claus Andersen, Patrick Bruneval, Marny Fedrigo, Michael C Fishbein, Martin Goddard, Elizabeth H Hammond, Ornella Leone, Charles Marboe, Dylan Miller, Desley Neil, Doris Rassl, Monica P Revelo, Alexandra Rice, E Rene Rodriguez, Susan Stewart, Carmela D Tan, Gayle L Winters, Lori WestMandeep R Mehra, Annalisa Angelini

Afdeling for Patologi

440 Citationer (Scopus)

Abstract

During the last 25 years, antibody-mediated rejection of the cardiac allograft has evolved from a relatively obscure concept to a recognized clinical complication in the management of heart transplant patients. Herein we report the consensus findings from a series of meetings held between 2010-2012 to develop a Working Formulation for the pathologic diagnosis, grading, and reporting of cardiac antibody-mediated rejection. The diagnostic criteria for its morphologic and immunopathologic components are enumerated, illustrated, and described in detail. Numerous challenges and unresolved clinical, immunologic, and pathologic questions remain to which a Working Formulation may facilitate answers.

Originalsprog	Engelsk
Tidsskrift	The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Vol/bind	32
Udgave nummer	12
Sider (fra-til)	1147-62
Antal sider	16
ISSN	1053-2498
DOI	https://doi.org/10.1016/j.healun.2013.08.011
Status	Udgivet - dec. 2013

Adgang til dokumentet

10.1016/j.healun.2013.08.011

Fingeraftryk

Dyk ned i forskningsemnerne om 'The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Berry, G. J., Burke, M. M., Andersen, C., Bruneval, P., Fedrigo, M., Fishbein, M. C., Goddard, M., Hammond, E. H., Leone, O., Marboe, C., Miller, D., Neil, D., Rassl, D., Revelo, M. P., Rice, A., Rene Rodriguez, E., Stewart, S., Tan, C. D., Winters, G. L., ... Angelini, A. (2013). The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 32(12), 1147-62. https://doi.org/10.1016/j.healun.2013.08.011

The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. / Berry, Gerald J; Burke, Margaret M; Andersen, Claus et al.
I: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, Bind 32, Nr. 12, 12.2013, s. 1147-62.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Berry, GJ, Burke, MM, Andersen, C, Bruneval, P, Fedrigo, M, Fishbein, MC, Goddard, M, Hammond, EH, Leone, O, Marboe, C, Miller, D, Neil, D, Rassl, D, Revelo, MP, Rice, A, Rene Rodriguez, E, Stewart, S, Tan, CD, Winters, GL, West, L, Mehra, MR & Angelini, A 2013, 'The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation', The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, bind 32, nr. 12, s. 1147-62. https://doi.org/10.1016/j.healun.2013.08.011

Berry GJ, Burke MM, Andersen C, Bruneval P, Fedrigo M, Fishbein MC et al. The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2013 dec.;32(12):1147-62. doi: 10.1016/j.healun.2013.08.011

Berry, Gerald J ; Burke, Margaret M ; Andersen, Claus et al. / The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. I: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2013 ; Bind 32, Nr. 12. s. 1147-62.

@article{5235a069d78d45ffb67279af30ea49bc,

title = "The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation",

abstract = "During the last 25 years, antibody-mediated rejection of the cardiac allograft has evolved from a relatively obscure concept to a recognized clinical complication in the management of heart transplant patients. Herein we report the consensus findings from a series of meetings held between 2010-2012 to develop a Working Formulation for the pathologic diagnosis, grading, and reporting of cardiac antibody-mediated rejection. The diagnostic criteria for its morphologic and immunopathologic components are enumerated, illustrated, and described in detail. Numerous challenges and unresolved clinical, immunologic, and pathologic questions remain to which a Working Formulation may facilitate answers.",

author = "Berry, {Gerald J} and Burke, {Margaret M} and Claus Andersen and Patrick Bruneval and Marny Fedrigo and Fishbein, {Michael C} and Martin Goddard and Hammond, {Elizabeth H} and Ornella Leone and Charles Marboe and Dylan Miller and Desley Neil and Doris Rassl and Revelo, {Monica P} and Alexandra Rice and {Rene Rodriguez}, E and Susan Stewart and Tan, {Carmela D} and Winters, {Gayle L} and Lori West and Mehra, {Mandeep R} and Annalisa Angelini",

year = "2013",

month = dec,

doi = "10.1016/j.healun.2013.08.011",

language = "English",

volume = "32",

pages = "1147--62",

journal = "The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation",

issn = "1053-2498",

publisher = "Elsevier Inc",

number = "12",

}

TY - JOUR

T1 - The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation

AU - Berry, Gerald J

AU - Burke, Margaret M

AU - Andersen, Claus

AU - Bruneval, Patrick

AU - Fedrigo, Marny

AU - Fishbein, Michael C

AU - Goddard, Martin

AU - Hammond, Elizabeth H

AU - Leone, Ornella

AU - Marboe, Charles

AU - Miller, Dylan

AU - Neil, Desley

AU - Rassl, Doris

AU - Revelo, Monica P

AU - Rice, Alexandra

AU - Rene Rodriguez, E

AU - Stewart, Susan

AU - Tan, Carmela D

AU - Winters, Gayle L

AU - West, Lori

AU - Mehra, Mandeep R

AU - Angelini, Annalisa

PY - 2013/12

Y1 - 2013/12

N2 - During the last 25 years, antibody-mediated rejection of the cardiac allograft has evolved from a relatively obscure concept to a recognized clinical complication in the management of heart transplant patients. Herein we report the consensus findings from a series of meetings held between 2010-2012 to develop a Working Formulation for the pathologic diagnosis, grading, and reporting of cardiac antibody-mediated rejection. The diagnostic criteria for its morphologic and immunopathologic components are enumerated, illustrated, and described in detail. Numerous challenges and unresolved clinical, immunologic, and pathologic questions remain to which a Working Formulation may facilitate answers.

AB - During the last 25 years, antibody-mediated rejection of the cardiac allograft has evolved from a relatively obscure concept to a recognized clinical complication in the management of heart transplant patients. Herein we report the consensus findings from a series of meetings held between 2010-2012 to develop a Working Formulation for the pathologic diagnosis, grading, and reporting of cardiac antibody-mediated rejection. The diagnostic criteria for its morphologic and immunopathologic components are enumerated, illustrated, and described in detail. Numerous challenges and unresolved clinical, immunologic, and pathologic questions remain to which a Working Formulation may facilitate answers.

U2 - 10.1016/j.healun.2013.08.011

DO - 10.1016/j.healun.2013.08.011

M3 - Journal article

C2 - 24263017

SN - 1053-2498

VL - 32

SP - 1147

EP - 1162

JO - The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

JF - The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

IS - 12

ER -